BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23750793)

  • 21. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2.
    Shimabukuro-Vornhagen A; Draube A; Liebig T; Popov A; Rothe A; von Bergwelt-Baildon M
    Oncol Rep; 2013 Mar; 29(3):1061-5. PubMed ID: 23292511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.
    Chung Y; Ko SY; Ko HJ; Kang CY
    Eur J Immunol; 2005 May; 35(5):1381-90. PubMed ID: 15827964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses.
    Rocha B; Tanchot C
    Curr Opin Immunol; 2004 Jun; 16(3):259-63. PubMed ID: 15134772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8 T cell priming by B lymphocytes is CD4 help dependent.
    Castiglioni P; Gerloni M; Cortez-Gonzalez X; Zanetti M
    Eur J Immunol; 2005 May; 35(5):1360-70. PubMed ID: 15816014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
    Ritchie DS; Yang J; Hermans IF; Ronchese F
    Scand J Immunol; 2004 Dec; 60(6):543-51. PubMed ID: 15584965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
    Schultze JL; Michalak S; Seamon MJ; Dranoff G; Jung K; Daley J; Delgado JC; Gribben JG; Nadler LM
    J Clin Invest; 1997 Dec; 100(11):2757-65. PubMed ID: 9389740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.
    Rasmussen IB; Oynebråten I; Høydahl LS; Flobakk M; Lunde E; Michaelsen TE; Bogen B; Sandlie I
    Protein Eng Des Sel; 2012 Mar; 25(3):89-96. PubMed ID: 22233931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE; Stavnezer J; Kikutani H; Parker DC
    J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro.
    Haase C; Michelsen BK; Jørgensen TN
    Scand J Immunol; 2004 Mar; 59(3):237-45. PubMed ID: 15030573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
    Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.